Clarifying Genetic Autism Risk in PTEN Patients

Germline mutations of the tumor suppressor gene PTEN are associated with a group of genetic disorders that increase the risk of certain cancers, cognitive and behavioral deficits, benign growths and tumors, and macrocephaly. A recent study suggests that copy number variations may act as genomic modifiers that influence the risk of autism spectrum disorder. Charis Eng, MD, PhD, discusses her latest discovery.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy